5453-99-6

Basic information

• Product Name: 4-Benzyl-morpholin-2-one
• Synonyms: 4-Benzyl-morpholin-2-one;N-Benzylmorpholine-2-one;NSC 18919
• CAS NO: 5453-99-6
• Molecular Formula: C₁₁H₁₃NO₂
• Molecular Weight: 191.22642
• Mol File: 5453-99-6.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 336.6°Cat760mmHg
• Flash Point: 141.1°C
• Appearance: /
• Density: 1.17g/cm³
• Vapor Pressure: 0.000111mmHg at 25°C
• Refractive Index: 1.561
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 5.08±0.20(Predicted)
• CAS DataBase Reference: 4-Benzyl-morpholin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Benzyl-morpholin-2-one(5453-99-6)
• EPA Substance Registry System: 4-Benzyl-morpholin-2-one(5453-99-6)

Safety Data

• Hazardous Substances Data: 5453-99-6(Hazardous Substances Data)

Usage

General Description

4-Benzyl-morpholin-2-one is a chemical compound with the molecular formula C13H15NO2. It is a morpholine derivative with a benzyl group attached to the nitrogen. 4-Benzyl-morpholin-2-one has been studied for its potential pharmacological properties, including its ability to act as a neurokinin-1 receptor antagonist and its potential as an anti-anxiety and anti-depressant agent. 4-Benzyl-morpholin-2-one has also been investigated for its potential use in the treatment of substance abuse and addiction. 4-Benzyl-morpholin-2-one has shown promise in preclinical studies and may have potential therapeutic applications in the future.

InChI:InChI=1/C11H13NO2/c13-11-9-12(6-7-14-11)8-10-4-2-1-3-5-10/h1-5H,6-9H2

Upstream product

• 101-32-6 N-benzyl-diethanolamine 
• 100-39-0 benzyl bromide 
• 124948-51-2 (E)-2-(benzylideneamino)ethanol 
• 104-63-2 N-Benzylethanolamine 
• 770-37-6 2-(N-benzylidenamino)ethanol 
• 105-39-5 chloroacetic acid ethyl ester 
• 100-52-7 benzaldehyde 
• 106-93-4 ethylene dibromide 
• 56-40-6 glycine 
• 5437-45-6 Benzyl bromoacetate 
• 131543-46-9 Glyoxal 
• 96-32-2 bromoacetic acid methyl ester 

Downstream Products

• 120800-83-1 2-[Benzyl-(2-hydroxy-ethyl)-amino]-1-pyrrolidin-1-yl-ethanone 
• 118460-24-5 methyl 2-(benzyl(2-hydroxyethyl)amino)acetate 
• 120800-80-8 1-[Benzyl-(2-hydroxy-ethyl)-amino]-2-methyl-propan-2-ol 
• 120800-82-0 {2-[Benzyl-(2-hydroxy-ethyl)-amino]-acetylamino}-acetic acid methyl ester 
• 120800-81-9 N-Benzyl-2-[benzyl-(2-hydroxy-ethyl)-amino]-acetamide 
• 101-32-6 N-benzyl-diethanolamine 
• 73933-20-7 N-benzyl-2-hydroxymorpholine 
• 120800-79-5 N-benzyl-N-(2-hydroxyethyl)glycine 
• 118460-15-4 [(2-Acetoxy-ethyl)-benzyl-amino]-acetic acid methyl ester 
• 4441-15-0 morpholin-2-one 
• 503187-88-0 (6S)-6-Benzyl-morpholin-2-one 
• 1375855-46-1 2-(benzyl(2-hydroxyethyl)amino)-N-(2-(3',6'-bis(diethylamino)-3-oxospiro[isoindoline-1,9'-xanthene]-2-yl)ethyl)acetamide 
• 159706-87-3 4-benzyl-3-(4-fluorophenyl)morpholin-2-one 

Relevant articles and documents

Facile Access to the 12-Membered Macrocyclic Ligand PCTA and Its Derivatives with Carboxylate, Amide, and Phosphinate Ligating Functionalities

We describe a convenient synthetic pathway to access the 12-membered PCTA macrocycle, a polyaminocarboxylate ligand for which its M2+ and M3+ complexes are commonly associated with applications in biomedical diagnostics and radiother

Optimization of gefitinib analogues with potent anticancer activity

The interactions of gefitinib (Iressa) in EGFR are hydrogen bonding and van der Waals forces through quinazoline and aniline rings. However the morpholino group of gefitinib is poorly ordered due to its weak electron density. A series of novel piperazino analogues of gefitinib where morpholino group substituted with various piperazino groups were designed and synthesized. Most of them indicated significant anti-cancer activities against human cancer cell lines. In particular, compounds 52-54 showed excellent potency against cancer cells. Convergent synthetic approach has been developed for the synthesis of gefitinib intermediate which can lead to gefitinib as well as numerous analogues.

A rhodamine appended tripodal receptor as a ratiometric probe for Hg 2+ ions

A new rhodamine appended tripodal receptor 1 has been designed and synthesized. The receptor selectively recognizes Hg2+ ions in CH 3CN-water (4:1, v/v; 10 μM tris HCl buffer, pH 7.0) by displaying a ratiometric change in emission. Additionally, the visual detection is possible by a sharp change in color. The receptor shows in vitro detection of Hg 2+ ions in human cervical cancer (HeLa) cells.